Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, and markets pharmaceutical products worldwide. The company offers prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone compilations; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine and donepezil for treating Alzheimer's disease; laninamivir for anti-influenza treatment; and silodosin for treating dysuria. It also provides olmesartan and Telmisartan antihypertensive agents; levofloxacin, an antibacterial agent; pravastatin and Rosuvastatin antihyperlipidemic agents; iohexol to enhance the visibility of diagnostic X-ray imaging; loxoprofen, an anti-inflammatory analgesic; and naloxegol for opioid-induced constipation treatment. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a cold remedy; Loxonin S, an anti-inflammatory analgesic; Transino for treating melisma/alleviating spots, freckles, and pigmentation; Minon, a moisturizing cleanser; and Clean Dental, an oral care product. Additionally, the company offers Influenza HA Vaccine; Rotarix Oral Liquid, a vaccine for prevention of rotavirus; ActHIB, a haemophilus influenzae type b vaccine; Live Attenuated Measles-Rubella Combined Vaccine; and Squarekids, a vaccine for the prevention of pertussis, diphtheria, tetanus, and poliomyelitis. It also offers pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has a strategic partnership with Ultragenyx Pharmaceutical Inc. The company was founded in 1899 and is headquartered in Tokyo, Japan. Show More...
-
Website http://www.daiichisankyo.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 23.80 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share JPY 59.42 99.52 14.73 90.81 86.41 456.62 119.11 79.44 91.1 143.88 229.33 Dividends JPY 30.0 60.0 60.0 60.0 60.0 60.0 60.0 70.0 70.0 70.0 70.0 Payout Ratio % * 60.2 529.1 95.4 47.0 46.1 46.9 72.4 120.1 67.8 30.5 Shares Mil 704.0 705.0 705.0 705.0 705.0 705.0 691.0 673.0 662.0 649.0 649.0 Book Value Per Share * EUR 10.31 10.26 9.82 9.69 12.1 14.86 15.47 14.1 15.34 17.39 Free Cash Flow Per Share * EUR 1.27 0.85 0.26 -0.13 0.72 0.49 1.32 0.67 0.47 Return on Assets % 2.81 4.72 0.69 4.21 3.48 16.79 4.24 2.8 3.16 4.69 7.48 Financial Leverage (Average) 1.73 1.74 1.88 1.85 1.89 1.52 1.54 1.63 1.68 1.67 1.57 Return on Equity % 4.85 8.19 1.25 7.86 6.53 28.2 6.49 4.44 5.22 7.84 11.61 Return on Invested Capital % 3.69 6.18 0.99 5.93 5.37 21.7 5.91 3.79 3.95 6.28 9.49 Interest Coverage 18.03 22.81 10.14 22.82 4.71 26.3 10.39 12.39 20.19 15.52 34.19 Current Ratio 3.05 2.91 2.18 2.16 2.15 2.64 2.96 3.67 3.4 3.62 4.31 Quick Ratio 2.04 2.04 1.39 1.4 1.68 2.08 2.54 3.15 2.88 3.12 3.74 Debt/Equity 0.32 0.26 0.25 0.23 0.27 0.15 0.14 0.24 0.23 0.18 0.14